GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹1,041 Cr | ₹980 Cr | ₹805 Cr | ₹974 Cr | ₹949 Cr | ₹1,011 Cr | ₹815 Cr | ₹930 Cr |
| Expenses | ₹670 Cr | ₹644 Cr | ₹554 Cr | ₹641 Cr | ₹658 Cr | ₹689 Cr | ₹584 Cr | ₹673 Cr |
| Operating Income | ₹371 Cr | ₹336 Cr | ₹251 Cr | ₹333 Cr | ₹292 Cr | ₹322 Cr | ₹231 Cr | ₹257 Cr |
| Other Income | ₹32 Cr | ₹34 Cr | ₹44 Cr | ₹41 Cr | ₹35 Cr | ₹35 Cr | ₹36 Cr | ₹30 Cr |
| Interest | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Depreciation | ₹20 Cr | ₹17 Cr | ₹16 Cr | ₹15 Cr | ₹19 Cr | ₹17 Cr | ₹16 Cr | ₹18 Cr |
| Profit Before Tax | ₹400 Cr | ₹354 Cr | ₹279 Cr | ₹359 Cr | ₹308 Cr | ₹344 Cr | ₹249 Cr | ₹271 Cr |
| Profit After Tax | ₹296 Cr | ₹257 Cr | ₹205 Cr | ₹263 Cr | ₹230 Cr | ₹253 Cr | ₹182 Cr | ₹194 Cr |
| EPS | ₹17.45 | ₹15.20 | ₹12.10 | ₹15.52 | ₹13.57 | ₹14.90 | ₹10.76 | ₹11.48 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GLAXOSMITHKLINE PHARMACEUTICALS | -5.2% | -11.2% | -19.6% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.5% | 1.6% | 1.3% |
| DIVIS LABORATORIES | -2% | -4.3% | 3.3% |
| CIPLA | -3.9% | -9.1% | -18.4% |
| TORRENT PHARMACEUTICALS | -0.8% | 0.5% | 32% |
| DR REDDYS LABORATORIES | -2.7% | -1.6% | 6.9% |
| MANKIND PHARMA | -5.5% | -2% | -11.1% |
| ZYDUS LIFESCIENCES | -1.4% | -1.6% | -5.4% |
| LUPIN | 1.3% | 5.1% | 11.5% |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 6.26 % |
| Y-o-Y | 9.67 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹1,041 Cr | 6.26 | |
| Sep2025 | ₹980 Cr | 21.71 | |
| Jun2025 | ₹805 Cr | -17.37 | |
| Mar2025 | ₹974 Cr | 2.63 | |
| Dec2024 | ₹949 Cr | -6.07 | |
| Sep2024 | ₹1,011 Cr | 24.07 | |
| Jun2024 | ₹815 Cr | -12.38 | |
| Mar2024 | ₹930 Cr | - | |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 10.61 % |
| Y-o-Y | 27.21 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹371 Cr | 10.61 | |
| Sep2025 | ₹336 Cr | 33.65 | |
| Jun2025 | ₹251 Cr | -24.61 | |
| Mar2025 | ₹333 Cr | 14.14 | |
| Dec2024 | ₹292 Cr | -9.26 | |
| Sep2024 | ₹322 Cr | 39.55 | |
| Jun2024 | ₹231 Cr | -10.39 | |
| Mar2024 | ₹257 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 4.09 % |
| Y-o-Y | 15.97 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | 35.66% | 4.09 | |
| Sep2025 | 34.26% | 9.81 | |
| Jun2025 | 31.2% | -8.77 | |
| Mar2025 | 34.2% | 11.22 | |
| Dec2024 | 30.75% | -3.39 | |
| Sep2024 | 31.83% | 12.47 | |
| Jun2024 | 28.3% | 2.28 | |
| Mar2024 | 27.67% | - | |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 14.81 % |
| Y-o-Y | 28.60 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹296 Cr | 14.81 | |
| Sep2025 | ₹257 Cr | 25.60 | |
| Jun2025 | ₹205 Cr | -22.01 | |
| Mar2025 | ₹263 Cr | 14.35 | |
| Dec2024 | ₹230 Cr | -8.96 | |
| Sep2024 | ₹253 Cr | 38.49 | |
| Jun2024 | ₹182 Cr | -6.25 | |
| Mar2024 | ₹194 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 8.03 % |
| Y-o-Y | 17.27 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | 28.39 % | 8.03 | |
| Sep2025 | 26.28 % | 3.22 | |
| Jun2025 | 25.46 % | -5.63 | |
| Mar2025 | 26.98 % | 11.44 | |
| Dec2024 | 24.21 % | -3.08 | |
| Sep2024 | 24.98 % | 11.62 | |
| Jun2024 | 22.38 % | 6.98 | |
| Mar2024 | 20.92 % | - | |
GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 14.80 % |
| Y-o-Y | 28.59 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹17.45 | 14.80 | |
| Sep2025 | ₹15.2 | 25.62 | |
| Jun2025 | ₹12.1 | -22.04 | |
| Mar2025 | ₹15.52 | 14.37 | |
| Dec2024 | ₹13.57 | -8.93 | |
| Sep2024 | ₹14.9 | 38.48 | |
| Jun2024 | ₹10.76 | -6.27 | |
| Mar2024 | ₹11.48 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD